1st Quarter - Report

LUNDBECK LLC for LUNDBECK LLC

Firm
Client
Income
—
Expenses
$201,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - 340b, orphan drugs S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - pharmaceutical company fees S. 301 - physician payments PDUFA Reauthorization Orphan Drug Act

Foreign entity interest: Assessing impact of health reform on patient access to innovative medications and on the US business.

LobbyistCovered position, as disclosed
MICHAEL J EGING —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th), H.R. 3962 (111th), H.R. 1298 (111th), S. 301 (111th), H.R. 4872 (111th), H.R. 3590 (111th), S. 1796 (111th), S. 525 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.